BiotechTubeBiotechTube
Home/Biocon/Indranil Sen
IS

Indranil Sen

Chief Financial Officer

Biocon

Therapeutic Areas

DiabetesOncologyImmunologyAutoimmune DiseasesNephrology

Biocon Pipeline

DrugIndicationPhase
Semglee (Insulin Glargine)DiabetesApproved
Ogivri (Trastuzumab)Breast CancerApproved
Fulphila (Pegfilgrastim)NeutropeniaApproved
Hulio (Adalimumab)Autoimmune DiseasesApproved
Bmab (Bevacizumab)CancerApproved
Insulin AspartDiabetesPhase 3
TocilizumabRheumatoid ArthritisFiled
DenosumabOsteoporosisPhase 3

Leadership Team at Biocon

KM
Kiran Mazumdar-Shaw
Executive Chairperson and Founder
SM
Siddharth Mittal
CEO and Managing Director
ST
Shreehas Tambe
CEO, Biocon Biologics
KU
Kedar Upadhye
Global Head, Clinical Development and Medical Affairs
AC
Arun Chandavarkar
COO and Joint MD
RW
Russell Walls
Independent Director
MD
Meleveetil Damodaran
Independent Director
BK
Bobby Kanubhai Parikh
Independent Director
NC
Nirav Chandra Merchant
Independent Director
MH
Mary Harney
Independent Director
View full Biocon profile